Latest Zika Research
Epidemic potential of Zika virus in Australia: implications for blood transfusion safety
Peter Watson‐Brown, Elvina Viennet, Gina Mincham, Craig R. Williams, Cassie C. Jansen, Brian L. Montgomery, Robert L.P. Flower, Helen M. Faddy (January 2019)
Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusions
Seema Kacker, Evan M. Bloch, Paul M. Ness, Eric A. Gehrie, Christi E. Marshall, Parvez M. Lokhandwala, Aaron A.R. Tobian (January 2019)
Duplex nucleic acid test for the detection of chikungunya and dengue RNA viruses in blood donations
Susan L. Stramer, Jean Stanley, Megan L. Nguyen, Rasa Bertuzis, Nancy Huynh, John R. Duncan, Patrick Albrecht, Lisa L. Pate, Susan A. Galel (January 2019)
Interpretation of pathogen load in relationship to infectivity and pathogen reduction efficacy
(December 2018)
International survey on the impact of parasitic infections: frequency of transmission and current mitigation strategies
David A. Leiby, Sheila F. O'Brien, Silvano Wendel, Megan L. Nguyen, Gilles Delage, Sushil G. Devare, Anthony Hardiman,Hira L. Nakhasi, Silvia Sauleda, Evan M. Bloch, for the WPTTID Subgroup on Parasites (December 2018)
The impact of Babesia microti blood donation screening
Laura Tonnetti, Rebecca L. Townsend, Barbara M. Deisting, James M. Haynes, Roger Y. Dodd, Susan L. Stramer (November 2018)
Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion related adverse reactions in the United States
Chris Edens, Kathryn A. Haass, Melissa Cumming, Anthony Osinski, Lynne O'Hearn, Kelly Passanisi, Lynn Eaton, Paul Visintainer, Alexandra Savinkina, Matthew J. Kuehnert, Sridhar V. Basavaraju, Chester Andrzejewski (November 2018)
Blood transfusion safety in sub Saharan Africa: A literature review of changes and challenges in the 21st century
A. Weimer, C.T. Tagny, J.B. Tapko, C. Gouws, A.A.R. Tobian, P.M. Ness, E.M. Bloch (October 2018)
Risk based decision making in transfusion medicine
Judie Leach Bennett, Dana V. Devine (September 2018)
Blood transfusion in sub Saharan Africa: understanding the missing gap and responding to present and future challenges
Lassina Barro, Victor J. Drew, Ghislain G. Poda, Claude T. Tagny, Magdy El‐Ekiaby, Shirley Owusu‐Ofori, Thierry Burnouf (September 2018)
Production and characterization of Zika virus RNA reference reagents as a response to a public health emergency
Rafaelle Fares‐Gusmao, Caren Chancey Evgeniya Volkova Andriyan Grinev Emilia Sippert Zhen Jiang Maria Rios (September 2018)
Our experience in riboflavin and ultraviolet light pathogen reduction technology for platelets: from platelet production to patient care
Teresa Jimenez‐Marco, Marta Garcia‐Recio, Enrique Girona‐Llobera (August 2018)
Prevalence of Zika Virus (Zikv) in blood donors from a hemotherapy service of the southern region of Brazil
C. F. Diefenbach, S. N. Slavov, S. Kashima, A. R. Ferreira, M. R. Hespanhol, B. S. Bandeira, B. S. Vizzotto, L. M. F. Krause, J. S. Martins (June 2018)
Seroprevalence of Zika Virus and Rubella Virus IgG among blood donors in Rwanda and in Sweden
Eric Seruyange, Jean‐Bosco Gahutu, Claude Mambo Muvunyi, Swaibu Katare, Vedaste Ndahindwa, Hassan Sibomana, José Nyamusore, Florent Rutagarama, Charles Hannoun, Helene Norder, Tomas Bergström (April 2018)
Red blood cells treated with the amustaline (S 303) pathogen reduction system: a transfusion study in cardiac surgery
Veronika Brixner, Arndt‐Holger Kiessling, Katharina Madlener, Markus M. Müller, Johannes Leibacher, Sarah Dombos, Iuliia Weber, Hans‐Ulrich Pfeiffer, Christof Geisen, Michael Schmidt, Reinhard Henschler, Anne North, Norman Huang, Nina Mufti, Anna Erickson, Christine Ernst, Salvador Rico, Richard J. Benjamin, Laurence M. Corash, Erhard Seifried (March 2018)
Refrigeration, cryopreservation and pathogen inactivation: an updated perspective on platelet storage conditions
L. Waters, M. Cameron, M. P. Padula, D. C. Marks, L. Johnson (February 2018)
The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in blood donors
Daniele Rocha, Elisabete Andrade, Daniela T. Godoy, Marcela Fontana‐Maurell, Elaine Costa ,Marisa Ribeiro, Antônio G.P. Ferreira, Rodrigo Brindeiro, Amilcar Tanuri, Patrícia Alvarez (January 2018)
Haematology patients and the risk of transfusion transmitted infection
Louise I. Ainley, Patricia E Hewitt (January 2018)
Ross River virus in Australian blood donors: possible implications for blood transfusion safety
Helen M. Faddy, Thu V. Tran, Veronica C. Hoad, Clive R. Seed, Elvina Viennet, Hiu‐Tat Chan, Robert Harley, Elise Hewlett, Roy A. Hall, Helle Bielefeldt‐Ohmann, Robert L.P. Flower, Natalie A. Prow (January 2018)
Inactivation of chikungunya virus in blood components treated with amotosalen/ultraviolet A light or amustaline/glutathione
Andrew Laughhunn, Yan‐Jang S. Huang, Dana L. Vanlandingham, Marion C. Lanteri, Adonis Stassinopoulos (January 2018)
Zika virus RNA polymerase chain reaction on the utility channel of a commercial nucleic acid testing system
Mohamed Boujnan, Ashley J. Duits, Marco H.G.M. Koppelman (January 2018)
Amustaline (S 303) treatment inactivates high levels of Chikungunya virus in red blood cell components
M. Aubry, A. Laughhunn, F. Santa Maria, M. C. Lanteri, A. Stassinopoulos, D. Musso (January 2018)
Emerging infectious disease outbreaks: estimating disease risk in Australian blood donors travelling overseas
A. Coghlan, V. C. Hoad, C. R. Seed, R. LP. Flower, R. J. Harley, D. Herbert, H. M. Faddy (October 2017)
Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathione
Maite Aubry, Andrew Laughhunn, Felicia Santa Maria, Marion C. Lanteri, Adonis Stassinopoulos, Didier Musso (September 2017)
Zika virus RNA detection in asymptomatic blood donors during an outbreak in the northeast region of São Paulo State, Brazil, 2016
Svetoslav N. Slavov, Marta R. Hespanhol, Evandra S. Rodrigues, José E. Levi, Eugênia M.A. Ubiali, Dimas T. Covas, Simone Kashima (September 2017)
Pathogen reduction of whole blood: utility and feasibility
J.‐P. Allain, R. Goodrich (September 2017)
Mitigation of the threat posed to transfusion by donors traveling to Zika affected areas: a Canadian risk based approach
Marc Germain, Gilles Delage, Sheila F. O'Brien, Yves Grégoire, Margaret Fearon, Dana Devine (July 2017)
How do we manage blood donors and recipients after a positive Zika screening result?
Alexandra Jimenez, Beth H. Shaz, Debra Kessler, Evan M. Bloch (July 2017)
Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light
Jesse J. Fryk, Denese C. Marks, Jody Hobson‐Peters, Daniel Watterson, Roy A. Hal,l Paul R. Young, Stefan Reichenberg, Frank Tolksdorf, Chryslain Sumian, Ute Gravemann, Axel Seltsam, Helen M. Faddy (July 2017)
Addressing the risk of bacterial contamination in platelets: a hospital economic perspective
Justin W. Li, Mark E. Brecher, Jessica L. Jacobson, Sarah K. Harm, Dorothy Chen, Audrey El‐Gamil, Al Dobson Paul D. Mintz (July 2017)
Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination
Felicia Santa Maria, Andrew Laughhunn, Marion C. Lanteri, Maite Aubry, Didier Musso, Adonis Stassinopoulos (July 2017)
Cost projections for implementation of safety interventions to prevent transfusion transmitted Zika virus infection in the United States
Katherine D. Ellingson, Mathew R.P. Sapiano, Kathryn A. Haass, Alexandra A. Savinkina, Misha L. Baker, Richard A. Henry, James J. Berger, Matthew J. Kuehnert, Sridhar V. Basavaraju (June 2017)
Continued decline in blood collection and transfusion in the United States–2015
Katherine D. Ellingson, Mathew R. P. Sapiano, Kathryn A. Haass, Alexandra A. Savinkina, Misha L. Baker, Koo‐Whang Chung, Richard A. Henry, James J. Berger, Matthew J. Kuehnert, Sridhar V. Basavaraju (June 2017)
Harmonization of nucleic acid testing for Zika virus: development of the 1st World Health Organization International Standard
Sally A. Baylis, Kay‐Martin O. Hanschmann, Barbara S. Schnierle, Jan‐Hendrik Trösemeier, Johannes Blümel, and the Zika Virus Collaborative Study Group (February 2017)
First cases of Zika virus–infected US blood donors outside states with areas of active transmission
Phillip C. Williamson, Jeffrey M. , Debra A. Kessler, Beth H. Shaz, Hany Kamel, Ralph R. Vassallo, Valerie Winkelman, Kui Gao, Rainer Ziermann, Juscilene Menezes, Stephen Thomas, Jerry A. Holmberg, Sonia Bakkour, Mars Stone, Kai Lu, Graham Simmons, Michael P. Busch (February 2017)
Relative analytical sensitivity of donor nucleic acid amplification technology screening and diagnostic real time polymerase chain reaction assays for detection of Zika virus RNA
Mars Stone, Marion C. Lanteri, Sonia Bakkour, Xutao Deng, Susan A. Galel, Jeffrey M. Linnen, Jorge L. Muñoz‐Jordán, Robert S. Lanciotti, Maria Rios, Pierre Gallian, Didier Musso, José E. Levi, Ester C. Sabino, Lark L. Coffey, Michael P. Busch (February 2017)
Zika virus and blood transfusion: the experience of French Polynesia
Damien Bierlaire, Sylvie Mauguin, Julien Broult, Didier Musso (February 2017)
Amustaline (S 303) treatment inactivates high levels of Zika virus in red blood cell components
Andrew Laughhunn, Felicia Santa Maria, Julien Broult, Marion C. Lanteri, Adonis Stassinopoulos, Didier Musso, Maite Aubry (February 2017)
Risk of exposure to blood products during pregnancy: guidance for Zika and other donor deferral policies
Malia S.Q. Murphy, Nadine Shehata, Jo Ann Colas, Michaël Chassé, Dean A. Fergusson, Sheila F. O'Brien, Mindy Goldman, Alan Tinmouth, Alan J. Forster, Kumanan Wilson (February 2017)
First Zika positive donations in the continental United States
Susan A. Galel, Phillip C. Williamson, Michael P. Busch, Danielle Stanek, Sonia Bakkour, Mars Stone, Kai Lu, Scott Jones, Susan N. Rossmann, Lisa Lee Pate, the cobas Zika IND Study Group (February 2017)